Senate Pushes for FTC Progress in PBM Investigation
Senate Commerce Committee leaders, Maria Cantwell and Chuck Grassley, along with 12 lawmakers, are requesting…
Browsing: State
“Plan E”: A Proposal for a Universal Benefit for Cell and Gene Therapies
Cell and gene therapies (CGTs) have provided new optimism for patients living with diseases previously…
Canadians Express Concerns Regarding Florida’s Importation Program
Florida’s plan to import prescription drugs from Canada is facing a potential setback as Canadian…
CMS Finalizes Electronic Prior Authorization Rule
On January 17, 2024, the Centers for Medicare & Medicaid Services (CMS) finalized the CMS…
Aimed Alliance Release New Resources on PDABs
On January 22, 2024, Aimed Alliance published two new resources on prescription drug affordability boards…
FDA Authorizes Florida’s Drug Importation Program
On January 5, 2024, the U.S. Food and Drug Administration (FDA) approved Florida’s Agency for…
Aimed Alliance Submits Comment on 2025 Medicare Part D Rule
On January 5, 2024, Aimed Alliance submitted a comment on the Medicare Program Contract Year…
Aimed Alliance Submits Comment on 2025 NBPP
On January 8, 2024, Aimed Alliance submitted a comment to the Centers for Medicare and…
Why Congress and the FDA Must Regulate CBD Consumer Products Now
On January 3, 2024, CareTalk published an opinion piece authored by Michael C. Barnes, Counsel…
CBO Responds to Calls from the House Budget Committee to Consider New Data on IRA Impact on Innovation
Responding to inquiries from the House Budget Committee, the Congressional Budget Office (CBO) has signaled…